The tweet was deleted by the author.
But we saved everything 🙂.
NovoCure Ltd will announce its financial results for the first quarter of 2026 on April 30. The company disclosed the upcoming release in a recent press statement.
Investors and analysts will closely watch the results as they assess NovoCure Ltd's business performance and market outlook for the start of the new fiscal year. More information is available in the official press release.
NovoCure Ltd recently reported positive Phase 2 trial results for its TTFields therapy in the PANOVA-4 study. The company continues to focus on innovative cancer treatments. Investors will review the upcoming financial results in the context of this recent clinical progress.